Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted December 23, 2016
Weight Loss Supplement Found to Contain Antidepressant
Fluoxetine is an FDA approved selective serotonin reuptake inhibitor (SSRI) drug prescribed to treat depression, anxiety, and other conditions. SSRI drugs are associated with serious side effects including suicidal thinking, abnormal bleeding, and seizures, and can interact with other common medications such as aspirin and ibuprofen, which can cause ventricular arrhythmia or sudden death.
Sibutramine, the active ingredient in the obesity drug Meridia, was removed from the U.S. market in October 2010 because it can substantially increase blood pressure and pulse rate in some individuals, and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This drug may also interact, in life-threatening ways, with other medications a consumer may be taking. Desmethylsiburamine is similar to sibutramine.
Consumers who have purchased this supplement should discontinue use immediately and contact their healthcare provider if they have experienced any adverse side effects. Consumers and healthcare providers are also encouraged to report any adverse reactions to the FDA's MedWatch Adverse Event Reporting Program.
See ConsumerLab.com's Review of Weight Loss Supplements for tests of related products.
See Related Warnings:
For more recalls and warnings, use the link below.